Michael P. Lux
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
Papers in
- Oncology 93
- HER2/EGFR in Cancer Research 30
- Cancer Treatment and Pharmacology 18
-
- Breast Cancer Treatment Studies 61
- Cancer Genomics and Diagnostics 13
- Co-authors
- Peter A. Fasching (128 shared papers)Matthias W. Beckmann (87 shared papers)Mayada R. Bani (33 shared papers)Claudia Rauh (43 shared papers)Michael Schrauder (35 shared papers)Michael Untch (8 shared papers)Christian R. Loehberg (45 shared papers)Arndt Hartmann (31 shared papers)
- Journals
- Breast Care (16 papers)Breast Cancer Research and Treatment (12 papers)European Journal of Cancer Prevention (11 papers)Archives of Gynecology and Obstetrics (10 papers)Annals of Oncology (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael P. Lux
235 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 145
- Cancer Research 1.2k
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.0k
- Genetics 274
- Pathology and Forensic Medicine 313
Countries citing papers authored by Michael P. Lux
This map shows the geographic impact of Michael P. Lux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Lux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Lux more than expected).
Fields of papers citing papers by Michael P. Lux
This network shows the impact of papers produced by Michael P. Lux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Lux. The network helps show where Michael P. Lux may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael P. Lux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 278 | |
| 2 | 2011 | 244 | |
| 3 | 2012 | 206 | |
| 4 | 2005 | 137 | |
| 5 | 2013 | 128 | |
| 6 | 2010 | 109 | |
| 7 | 1999 | 98 | |
| 8 | 1993 | 92 | |
| 9 | 2011 | 88 | |
| 10 | 2017 | 87 | |
| 11 | 2016 | 86 | |
| 12 | 2008 | 85 | |
| 13 | 2008 | 81 | |
| 14 | 2009 | 76 | |
| 15 | 2007 | 75 | |
| 16 | 2008 | 70 | |
| 17 | 2006 | 67 | |
| 18 | 2006 | 65 | |
| 19 | 2012 | 59 | |
| 20 | 2015 | 58 |
About Michael P. Lux
Michael P. Lux is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Economics and Econometrics, having authored 259 papers that have together received 4.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (61 papers), BRCA gene mutations in cancer (40 papers), Advanced Breast Cancer Therapies (40 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Treatment and Pharmacology (18 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Economic and Financial Impacts of Cancer (14 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.0k citations), Genetics (274 citations) and Pathology and Forensic Medicine (313 citations). Michael P. Lux has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter A. Fasching, Matthias W. Beckmann, Mayada R. Bani, Claudia Rauh, Michael Schrauder, Michael Untch, Christian R. Loehberg, Arndt Hartmann, Alexander Hein and Sebastian M. Jud. Their work appears in journals such as Breast Care, Breast Cancer Research and Treatment, European Journal of Cancer Prevention, Archives of Gynecology and Obstetrics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.